ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.2488A>G (p.Asn830Asp) (rs574039421)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000132391 SCV000187483 uncertain significance Hereditary cancer-predisposing syndrome 2017-06-02 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient or conflicting evidence
Invitae RCV000168262 SCV000218933 uncertain significance Hereditary breast and ovarian cancer syndrome 2014-12-03 criteria provided, single submitter clinical testing This sequence change replaces asparagine with aspartic acid at codon 830 of the BRCA2 protein (p.Asn830Asp). The asparagine residue is weakly conserved and there is a small physicochemical difference between asparagine and aspartic acid. This sequence change has not been published in the literature and is present in population databases (no rsID, 0.07%). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this sequence change is likely to be tolerated, but these predictions have not been confirmed by published functional studies. In summary, this is a rare missense change that is not predicted to affect protein function or cause disease. However the evidence is insufficient at this time to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000222546 SCV000278840 likely benign not specified 2018-03-12 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Color RCV000132391 SCV000683487 uncertain significance Hereditary cancer-predisposing syndrome 2018-09-03 criteria provided, single submitter clinical testing
Counsyl RCV000662824 SCV000785667 uncertain significance Breast-ovarian cancer, familial 2 2017-10-25 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000222546 SCV000918903 likely benign not specified 2018-04-30 criteria provided, single submitter clinical testing Variant summary: BRCA2 c.2488A>G (p.Asn830Asp) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 1.2-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in BRCA2 causing Hereditary Breast and Ovarian Cancer phenotype (0.00075), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. The variant, c.2488A>G, has been reported in the literature in individuals affected with Hereditary Breast and Ovarian Cancer Rajkumar_2015, Tung_2014). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast and Ovarian Cancer. Co-occurrences with other pathogenic variant(s) have been reported (BRCA2 c.7007G>A, p.Arg2336His (internally scored as a Pathogenic)), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Multiple ClinVar submissions from clinical diagnostic laboratories cite the variant with conflicting classifications, "uncertain significance" (2x) and "likely benign" (1x). Based on the evidence outlined above, the variant was classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.